ÜBER DIESE EPISODE

Englisch
Kanada

TRANSKRIPT 🔗

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Breaking Innovation Paralysis durchsuchen.

WEITERE EPISODEN IN DIESEM PODCAST

Dr. Anu Rebbapragada has spent over two decades translating diagnostic innovation into clinically trusted, commercially viable services — as a clinical microbiologist and high-complexity lab director, a national leader across Canadian diagnostic lab networks, a MedTech executive at a Fortune 500 gl…
Dr. Andrew Maxwell has spent three decades studying how people inside institutions actually make innovation decisions, from his early years at ABB through a PhD examining investor judgment to his current role as a professor of technology and entrepreneurship at York University's Lassonde School of …
Dr. Jeffrey Crelinsten is the publisher of Research Money — Canada's leading source of intelligence on science, technology, and innovation funding — and founder of The Impact Group, an innovation-policy consultancy he started nearly 40 years ago. Research Money's readership is more than half govern…
Dr. Kostas Trakas is a pharma builder and former Johnson & Johnson executive, and co-founder of Exsilios Pharma — a Canadian specialty pharmaceutical company that sources FDA, EMA, and MHRA-approved late-stage assets and secures Canadian commercialization rights across rare disease, oncology, i…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Natalie Yeadon, Founder and CEO, Augmentios, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.